Harrow, Inc. Common Stock (HROW)
PHARMACEUTICAL PREPARATIONS
Harrow, Inc. Common Stock (HROW) is listed on Nasdaq, where it has traded since April 30, 2007.
- Listed On
- Nasdaq
- Listed Since
- April 30, 2007
- Employees
- 373
- Market Cap
- $1.2B
About Harrow, Inc. Common Stock
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 217 institutions reported holding HROW, with 21.5 million shares worth $912.6 million in aggregate. The largest reported holder was BlackRock, with 2.7 million shares worth $116.4 million. Of the 5 largest holders listed below, 1 opened a new position in HROW, 3 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 2,740,117 | $116M | Added 7.34% |
| Opaleye Management | 2,400,000 | $102M | Reduced 15.26% |
| Vanguard | 2,012,614 | $85M | Added 2.48% |
| Private Capital Management | 1,598,770 | $68M | Added 2.35% |
| Deep Track Capital | 969,000 | $41M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is HROW?
Harrow, Inc. Common Stock (HROW) is listed on Nasdaq, where it has traded since April 30, 2007.
Who are the largest institutional holders of HROW?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of HROW were BlackRock, Opaleye Management and Vanguard.
How many institutions own HROW?
217 institutions reported a position in HROW for the quarter ended June 30, 2026, worth $912.6 million in total.
Did institutions buy or sell HROW last quarter?
Of the 5 largest reported holders, 1 opened a new position in HROW, 3 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for HROW.
Every reported institutional holder, plus insider and congressional trades in HROW, on SentiSense.